LabCorp’s at-Home Covid-19 Collection Kits Approved as OTC

December 9, 2020, 11:01 PM UTC

LabCorp says U.S. FDA granted emergency use authorization for the Pixel by LabCorp™ covid-19 test home collection kit.

  • Collection kit to become the first over the counter product in the U.S.
  • Approval will enable LabCorp to potentially distribute the kit through retail channels

To view the source of this information click here

To contact the reporter on this story:
Linly Lin in San Francisco at llin153@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.